Article

Jeffrey Berger, MD, Addresses Adherence in Acute Coronary Syndrome

Jeffrey Berger, MD, Assistant Professor, NYU Langone Medical Center, says that improving adherence of therapies in patients with acute coronary syndrome is a major goal.

Jeffrey Berger, MD, Assistant Professor, NYU Langone Medical Center, says that improving adherence of therapies in patients with acute coronary syndrome is a major goal. Utilizing all of the data gathered will help and motivate patients to understand and become adherent.

"Figuring out what are the best strategies, how can we motivate patients, how do we get them to take their drugs," said Dr Berger. "Really, the million dollar question right now is basically utilizing all of the data that we've gathered and really try to help patients use that information and become adherent."

This video was taken at the American College of Cardiology's 62nd Annual Scientific Session & Expo in San Francisco, CA, on March 11, 2013.

Related Videos
Richard J. Nowak, MD, MS, Yale School of Medicine
Drs Lillian L. Siu and Matthew G. Vander Heiden
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Kimberly Westrich, MA, chief strategy officer, NPC
Marla Black Morgan, MD, Phoebe Neurology Associates
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Bridgette Picou, LVN, ACLPN, The Well Project
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Richard Nowak, MD, MS, Yale School of Medicine
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo